Yunfeng Capital and Hybio Acquire German Pharmaceutical Firm
July 5, 2018 — 11:49 CST
This Data Is Locked!
This area is available only to Subscribers.
A consortium led by Jack Ma-backed Yunfeng Capital and Shenzhen-listed Chinese biopharmaceutical company Hybio Pharmaceutical has entered into an agreement to buy all the shares... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals